Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00100711 · TERMINATED
Trial details
- NCT number
- NCT00100711
- Sponsor
- Pharmacyclics LLC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2010-02-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.